The role of non-coding variants in Usher disease
非编码变异在亚瑟病中的作用
基本信息
- 批准号:10588508
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdultAllelesBiological AssayBiological ModelsBlindnessBrainCRISPR/Cas technologyCatalogsCell Culture SystemCell Culture TechniquesCellsChildhoodCiliaClassificationClinicalCodeComplexData SetDetectionDiagnosisDiseaseElectrophysiology (science)EngineeringExonsFamily memberGene TargetingGenesGenetic VariationGenomicsGenotypeHaplotypesHealthHumanIn VitroInheritedIntegral Membrane ProteinKidneyKnock-inLengthLightLiverLuciferasesMammalian CellMapsMendelian disorderMicroscopyModelingMutationNucleic Acid Regulatory SequencesOrganOrganoidsPathogenicityPatientsPatternPhasePhenotypePhotoreceptorsPopulationProteinsReporterRetinaRetinal DegenerationRetinal DiseasesRoleSensorineural Hearing LossTechnologyTherapeuticTissuesTransport ProcessUSH2A geneUntranslated RNAUsher SyndromeUsher Syndrome Type 2VariantVisionVisual impairmentautosomebaseciliopathyclinically relevantcohortcongenital hearing lossdeafnessdisease phenotypeepigenomicsexome sequencinggene productgenome sequencinghuman diseaseinduced pluripotent stem cellnanoporenovelrare variantreconstructionsensory neuropathystem cell differentiationstem cellstargeted sequencingvariant detection
项目摘要
PROJECT SUMMARY/ABSTRACT
Primary cilia, or non-motile cilia, are present in almost every mammalian cell. Ciliopathies cause a
spectrum of diseases in multiple organs, including the brain, kidney and liver. The most debilitating,
however, are sensory neuropathies leading to deafness and blindness. Retinal ciliopathies account for
one third of all inherited retinal diseases (IRDs), and are a major cause of visual impairment and
blindness in the pediatric population. Usher syndrome is the most common retinal ciliopathy and
presents a tremendous health burden due to congenital hearing impairment and progressive decline in
vision. Usher type 2 (USH2) is the most common subtype with the USH2A gene accounting for the
majority of cases. USH2 is inherited in an autosomal recessive manner; however, in approximately 20%
of patients with clinical features typical for USH2, only one mutation of USH2A has been identified by
exome sequencing, thereby precluding a definitive diagnosis. The second disease variant may reside in
non-coding regions of the USH2A gene. Whereas the protein coding variants of IRDs have been
studied in human and other model systems, the role of non-protein coding variants contributing to
monoallelic disease is much less understood. Non-coding variants are difficult to classify, especially in
gene products as large and complex as USH2A (spans 800 kilobases and contains 72 exons), and thus
remain under-diagnosed. Genome sequencing of IRD patients can identify pathogenic non-coding
variations in regulatory regions to explain causative changes and is increasingly being used to
genetically diagnose patients suffering from suspected monogenic disease. Phasing genetic variation is
also critical for human disease studies. We hypothesize that genomic sequencing and haplotype
phasing of the USH2A locus and its surrounding regulatory regions will provide a more accurate
detection of pathogenic variants in monoallelic patients. This will be accomplished by combining the
base-level accuracy of Illumina short-read sequencing with the longer read lengths obtained from
Nanopore based amplification-free targeted sequencing. Identification of non-coding variants and their
phase information are essential first steps towards understanding their pathogenic effects in patient-
derived stem cells. The pathogenicity of non-coding variants will be explored using luciferase knock-in
cell culture systems as well as patient-derived induced pluripotent stem cells (iPSCs) differentiated in
vitro to form retinal organoids (ROs). Use of ROs will provide clinically relevant tissue from patients that
can be edited using CRISPR-Cas9 technology to determine variant pathogenicity and mutational
burden. This proposal has tremendous therapeutic potential as non-coding deep-intronic variants have
been the focus of gene targeting and gene editing technologies in various IRDs.
项目概要/摘要
初级纤毛或非运动纤毛几乎存在于每个哺乳动物细胞中。纤毛病会导致
多个器官的疾病谱,包括脑、肾和肝。最让人衰弱的,
然而,感觉神经病会导致耳聋和失明。视网膜纤毛病占
占所有遗传性视网膜疾病 (IRD) 的三分之一,是视力障碍和视力障碍的主要原因
儿童失明。 Usher 综合征是最常见的视网膜纤毛病,
由于先天性听力障碍和听力逐渐下降,带来了巨大的健康负担
想象。 Usher 2 型 (USH2) 是最常见的亚型,USH2A 基因负责
大多数情况。 USH2 以常染色体隐性方式遗传;然而,大约 20%
在具有 USH2 典型临床特征的患者中,仅发现了一种 USH2A 突变
外显子组测序,从而排除了明确的诊断。第二种疾病变异可能存在于
USH2A 基因的非编码区。鉴于 IRD 的蛋白质编码变体已被
在人类和其他模型系统中研究发现,非蛋白质编码变体的作用有助于
对单等位基因疾病的了解要少得多。非编码变体很难分类,尤其是在
基因产物与 USH2A 一样大且复杂(跨度 800 KB,包含 72 个外显子),因此
仍处于诊断不足状态。 IRD 患者的基因组测序可识别致病性非编码
监管区域的变化来解释原因变化,并且越来越多地被用来
对患有疑似单基因疾病的患者进行基因诊断。定相遗传变异是
对于人类疾病研究也至关重要。我们假设基因组测序和单倍型
USH2A 基因座及其周围调控区域的定相将提供更准确的
检测单等位基因患者的致病变异。这将通过结合
Illumina 短读长测序的基本精度,其中较长读长来自
基于纳米孔的免扩增靶向测序。非编码变体的识别及其
阶段信息是了解其对患者致病作用的重要第一步
衍生干细胞。将使用荧光素酶敲入来探索非编码变异的致病性
细胞培养系统以及患者来源的诱导多能干细胞 (iPSC) 分化
体外形成视网膜类器官(RO)。 RO 的使用将提供来自患者的临床相关组织,
可以使用 CRISPR-Cas9 技术进行编辑以确定变异的致病性和突变性
负担。该提议具有巨大的治疗潜力,因为非编码深内含子变异已
一直是各个IRD基因打靶和基因编辑技术的焦点。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Contributed Session I: Correlating cone structure and function in retinitis pigmentosa using coarse-scale optoretinography (CoORG).
贡献会议 I:使用粗尺度视视网膜成像 (CoORG) 关联色素性视网膜炎中的视锥细胞结构和功能。
- DOI:
- 发表时间:2023
- 期刊:
- 影响因子:1.8
- 作者:Liu,Teng;Pandiyan,VimalPrabhu;Wendel,Benjamin;Slezak,Emily;Mustafi,Debarshi;Chao,Jennifer;Sabesan,Ramkumar
- 通讯作者:Sabesan,Ramkumar
Successful Treatment Response of a Juxtapapillary Retinal Capillary Hemangioblastoma Due to von Hippel-Lindau Syndrome with Belzutifan in a Pediatric Patient.
使用贝尔祖替芬对一名儿科患者因冯·希佩尔-林道综合征引起的近视乳头状视网膜毛细血管母细胞瘤的成功治疗反应。
- DOI:10.1097/iae.0000000000003973
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Mustafi,Debarshi;Huang,Johnson;Ting,MichelleA;Waligorski,Natalie;Stacey,AndrewW;Huang,LauraC
- 通讯作者:Huang,LauraC
Familial co-segregation and the emerging role of long-read sequencing to re-classify variants of uncertain significance in inherited retinal diseases.
- DOI:10.1038/s41525-023-00366-9
- 发表时间:2023-08-10
- 期刊:
- 影响因子:5.3
- 作者:Gupta, Pankhuri;Nakamichi, Kenji;Bonnell, Alyssa C. C.;Yanagihara, Ryan;Radulovich, Nick;Hisama, Fuki M. M.;Chao, Jennifer R. R.;Mustafi, Debarshi
- 通讯作者:Mustafi, Debarshi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Debarshi Mustafi其他文献
Debarshi Mustafi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Decoding the Paradox of DDX41-mutant MDS
解读 DDX41 突变型 MDS 的悖论
- 批准号:
10905168 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Identification of components and mechanisms regulating expanded CUG-repeat RNP complexes in Myotonic Dystrophy Type 1 muscle cells
强直性肌营养不良 1 型肌细胞中调节扩展 CUG 重复 RNP 复合物的成分和机制的鉴定
- 批准号:
10667708 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Left-right asymmetry and PITX2 in atrial fibrillation
心房颤动中的左右不对称和 PITX2
- 批准号:
10722197 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Environmental Moderation of Genetic Influences on Dementia Risk in Mexican Older Adults
环境调节基因对墨西哥老年人痴呆风险的影响
- 批准号:
10607226 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别: